Short- and long-term outcomes of adult allogeneic hematopoietic stem cell transplant patients admitted to the intensive care unit in the peritransplant period

References

• Armitage JO. Bone marrow transplantation. N Engl J Med. 1994;330:827–838.
   PubMed Web of Science ®Google Scholar
• Giralt S, Estey E, Albitar M, et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood. 1997;89:4531–4536.
   PubMed Web of Science ®Google Scholar
• Bertz H, Potthoff K, Finke J. Allogeneic stem-cell transplantation from related and unrelated donors in older patients with myeloid leukemia. J Clin Oncol. 2003;21:1480.
   PubMed Web of Science ®Google Scholar
• Soubani AO, Kseibi E, Bander JJ, et al. Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU. Chest. 2004;126:1604–1611.
   PubMed Web of Science ®Google Scholar
• Price KJ, Thall PF, Kish SK, et al. Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J Respir Crit Care Med. 1998;158:876–884.
   PubMed Web of Science ®Google Scholar
• Scales DC, Thiruchelvam D, Kiss A, et al. Intensive care outcomes in bone marrow transplant recipients: a population-based cohort analysis. Crit Care. 2008;12:R77.
   PubMed Web of Science ®Google Scholar
• Faber-Langendoen K, Caplan AL, McGlave PB. Survival of adult bone marrow transplant patients receiving mechanical ventilation: a case for restricted use. Bone Marrow Transplant. 1993;12:501–507.
   PubMed Web of Science ®Google Scholar
• Afessa B, Tefferi A, Dunn WF, et al. Intensive care unit support and acute physiology and chronic health evaluation III performance in hematopoietic stem cell transplant recipients. Crit Care Med. 2003;31:1715–1721.
   PubMed Web of Science ®Google Scholar
• Allareddy V, Roy A, Rampa S, et al. Outcomes of stem cell transplant patients with acute respiratory failure requiring mechanical ventilation in the United States. Bone Marrow Transplant. 2014;49:1278–1286.
   PubMed Web of Science ®Google Scholar
• Galindo-Becerra S, Labastida-Mercado N, Rosales-Padrón J, et al. Outcome of recipients of hematopoietic stem cell transplants who require intensive care unit support: a single institution experience. Acta Haematol. 2015;134:119–124.
   PubMed Web of Science ®Google Scholar
• Pène F, Aubron C, Azoulay E, et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol. 2006;24:643–649.
   PubMed Web of Science ®Google Scholar
• Neumann F, Lobitz O, Fenk R, et al. The sepsis-related organ failure assessment (SOFA) score is predictive for survival of patients admitted to the intensive care unit following allogeneic blood stem cell transplantation. Ann Hematol. 2008;87:299–304.
   PubMed Web of Science ®Google Scholar
• Gilli K, Remberger M, Hjelmqvist H, et al. Sequential organ failure assessment predicts the outcome of SCT recipients admitted to intensive care unit. Bone Marrow Transplant. 2010;45:682–688.
   PubMed Web of Science ®Google Scholar
• Mokart D, Granata A, Crocchiolo R, et al. Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: outcomes of patients admitted to intensive care unit. J Crit Care. 2015;30:1107–1113.
   PubMed Web of Science ®Google Scholar
• Townsend WM, Holroyd A, Pearce R, et al. Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning. Br J Haematol. 2013;161:578–586.
   PubMed Web of Science ®Google Scholar
• Kew AK, Couban S, Patrick W, et al. Outcome of hematopoietic stem cell transplant recipients admitted to the intensive care unit. Biol Blood Marrow Transplant. 2006;12:301–305.
   PubMed Web of Science ®Google Scholar
• Benz R, Schanz U, Maggiorini M, et al. Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT. Bone Marrow Transplant. 2014;49:62–65.
   PubMed Web of Science ®Google Scholar
• Castella X, Artigas A, Bion J, et al. A comparison of severity of illness scoring systems for intensive care unit patients: results of a multicenter, multinational study. The European/North American severity study group. Crit Care Med. 1995;23:1327–1335.
   PubMed Web of Science ®Google Scholar
• Giralt S, Ballen K, Rizzo D, et al. Reduced–intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant. 2009;15:367.
   PubMed Web of Science ®Google Scholar
• Reisner Y, Kapoor N, Kirkpatrick D, et al. Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet. 1981;2:327–331.
   PubMed Web of Science ®Google Scholar
• Tamari R, Chung SS, Papadopoulos EB, et al. CD34-selected hematopoietic stem cell transplants conditioned with myeloablative regimens and antithymocyte globulin for advanced myelodysplastic syndrome: limited graft-versus-host disease without increased relapse. Biol Blood Marrow Transplant. 2015;21:2106–2114.
   PubMed Web of Science ®Google Scholar
• Nash RA, Piñeiro LA, Storb R, et al. FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors. Blood. 1996;88:3634–3641.
   PubMed Web of Science ®Google Scholar
• Ponce DM, Sauter C, Devlin S, et al. A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantation. Biol Blood Marrow Transplant. 2013;19:799–803.
   PubMed Web of Science ®Google Scholar
• Cutler C, Kim HT, Hochberg E, et al. Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant. 2004;10:328–336.
   PubMed Web of Science ®Google Scholar
• Hosmer DW Jr., Lemeshow S. Applied logistic regression, 2nd ed., New York: John Wiley & Sons. 2000.
   Google Scholar
• Lin DY, Wei LJ, Ying Z. Checking the cox model with cumulative sums of martingale-based residuals. Biometrika. 1993;80:557–572.
   Web of Science ®Google Scholar
• Trinkaus MA, Lapinsky SE, Crump M, et al. Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit. Bone Marrow Transplant. 2009;43:411–415.
   PubMed Web of Science ®Google Scholar
• Kim SW, Kami M, Urahama N, et al. Feasibility of acute physiology and chronic health evaluation (APACHE) II and III score-based screening in patients receiving allogeneic hematopoietic stem-cell transplantation. Transplantation. 2003;75:566–570.
   PubMed Web of Science ®Google Scholar
• Jackson SR, Tweeddale MG, Barnett MJ, et al. Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplant. 1998;21:697–704.
   PubMed Web of Science ®Google Scholar
• Torrecilla C, Cortes JL, Chamarro C, et al. Prognostic assessment of the acute complications of bone marrow transplantation requiring intensive therapy. Intensive Care Med. 1988;14:393–398.
   PubMed Web of Science ®Google Scholar
• Huynh TN, Weigt SS, Belperio JA, et al. Outcome and prognostic indicators of patients with hematopoietic stem cell transplants admitted to the intensive care unit. J Transplant. 2009;2009:917294.
   PubMedGoogle Scholar
• Kersting S, Koomans HA, Hené RJ, et al. Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survival. Bone Marrow Transplant. 2007;39:359–365.
   PubMed Web of Science ®Google Scholar
• Sorror M, Storer B, Sandmaier BM, et al. Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation. Cancer. 2008;112:1992–2001.
   PubMed Web of Science ®Google Scholar
• Corradini P, Zallio F, Mariotti J, et al. Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies. J Clin Oncol. 2005;23:6690–6698.
   PubMed Web of Science ®Google Scholar
• Lengliné E, Chevret S, Moreau AS, et al. Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2015;50:840.
   PubMed Web of Science ®Google Scholar
• Bokhari SW, Munir T, Memon S, et al. Impact of critical care reconfiguration and track-and-trigger outreach team intervention on outcomes of haematology patients requiring intensive care admission. Ann Hematol. 2010;89:505–512.
   PubMed Web of Science ®Google Scholar
• Jaffe D, Jakubowski A, Sepkowitz K, et al. Prevention of peritransplantation viridans streptococcal bacteremia with early vancomycin administration: a single-center observational cohort study. Clin Infect Dis. 2004;39:1625–1632.
   PubMed Web of Science ®Google Scholar